Brain cancer patients who received this pain medication lived longer, study shows

Glioblastoma, the most aggressive and deadly type of brain cancer, is known to have a very poor prognosis — but a new study suggests that a pain-relieving drug could extend survival.

Researchers at Mass General Brigham have found that an already-approved medication — a pain reliever and anti-seizure medication called gabapentin — has been linked to improved survival in patients with glioblastoma.

The findings were published in Nature Communications last week.

MICHAEL BOLTON HAD...